+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
From
From
From
Sickle Cell Disease (SCD) - Pipeline Insight, 2024 - Product Thumbnail Image

Sickle Cell Disease (SCD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
From
From
From
From
Sickle Cell Disease - Competitive landscape, 2023 - Product Thumbnail Image

Sickle Cell Disease - Competitive landscape, 2023

  • Report
  • May 2023
  • 196 Pages
  • Global
From
Loading Indicator